Press releaseGlobe Newswire
Tempest Therapeutics
TPST · NASDAQ
$0.5762−$0.0239 (−3.98%)TodayMarket closed ·
Prev close $0.6001
Latest news
- Press releaseGlobe Newswire
Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsHenry Khederian
Tempest Therapeutics (TPST) Stock Surges Wednesday: What's Driving the Action?
- Press releaseGlobe Newswire
Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform
- Press releaseGlobe Newswire
Tempest Therapeutics Announces Up to $7.5 Million Private Placement
- Press releaseGlobe Newswire
Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- Press releaseGlobe Newswire
Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T
- Press releaseGlobe Newswire
Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026
- Press releaseGlobe Newswire
Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
- Press releaseGlobe Newswire
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds
- Press releaseGlobe Newswire
Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- Press releaseGlobe Newswire
Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
Tempest Announces Record Date for Anticipated Dividend Distribution of Warrants to Stockholders
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Crude Oil Falls Over 2%; Lowe's Shares Gain After Q3 Results
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsAvi Kapoor
Nasdaq Gains Over 100 Points; Target Trims Earnings Forecast
- NewsHenry Khederian
Why Tempest Therapeutics (TPST) Stock Is Down 45% Today
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releasePRNewswire
After Major Oncology Conference, All Eyes Turn to Industry Innovation
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
- NewsVandana Singh
Why Is Cancer Focused Tempest Therapeutics Stock Trading Higher On Thursday?
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.